This study is currently not recruiting participants.

EXTENSION STUDY EVALUATING TREATMENT WITH PF-05280586 VERSUS RITUXIMAB IN SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS WHO HAVE PARTICIPATED IN OTHER PF-05280586 CLINICAL TRIALS

Study Comparing Investigational Medication to Existing Treatment

Not Recruiting
18 years - 100 years
All
Phase N/A

Brief description of study.

The purpose of this research study is to investigate whether a new drug, PF-05280586, is similar in several major ways to a drug that is already available, rituximab.

Detailed description of study

The purpose of this research study is to investigate whether a new drug, PF-05280586, is similar in several major ways to a drug that is already available, rituximab.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Rheumatoid Arthritis
  • Age: 18 years - 100 years
  • Gender: All

This study investigates whether an investigational medication is similar in important ways to an existing treatment for certain conditions. The investigational medication is being compared to a treatment called rituximab, which is already available for use.

Participants in the study may receive the investigational medication or the existing treatment. The study aims to understand the similarities between these two treatments and involves various procedures to assess their effects.

  • Who can participate: Participants must meet specific age criteria and other eligibility factors, which are not specified in the provided information.
  • Study details: Participants will receive either the investigational medication or the existing treatment. The study will compare the effects of these treatments.
Updated on 19 Feb 2024. Study ID: 1212010156

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team